Literature DB >> 26449696

The case for expanding the definition of 'key populations' to include high-risk groups in the general population to improve targeted HIV prevention efforts.

Olive Shisana1, N Zungu, M Evans, K Risher, T Rehle, D Clementano.   

Abstract

BACKGROUND: Two additional key populations within the general population in South Africa (SA) that are at risk of HIV infection are black African women aged 20 - 34 years and black African men aged 25 - 49 years.
OBJECTIVE: To investigate the social determinants of HIV serostatus for these two high-risk populations.
METHODS: Data from the 2012 South African National HIV Prevalence, Incidence, and Behaviour Survey were analysed for black African women aged 20 - 34 years and black African men aged 25 - 49 years.
RESULTS: Of the 6.4 million people living with HIV in SA in 2012, 1.8 million (28%) were black women aged 20 - 34 years and 1.9 million (30%) black men aged 25 - 49 years. In 2012, they constituted 58% of the total HIV-positive population and 48% of the newly infected population. Low socioeconomic status (SES) was strongly associated (p<0.001) with being HIV-positive among black women aged 20 - 34 years, and was marginally significant among black men aged 25 - 49 years (p<0.1).
CONCLUSION: Low SES is a critical social determinant for HIV infection among the high-risk groups of black African women aged 20 - 34 years and black African men aged 25 - 49 years. Targeted interventions for these key populations should prioritise socioeconomic empowerment, access to formal housing and services, access to higher education, and broad economic transformation.

Entities:  

Year:  2015        PMID: 26449696     DOI: 10.7196/samjnew.7918

Source DB:  PubMed          Journal:  S Afr Med J


  6 in total

1.  A risk measurement tool for targeted HIV prevention measures amongst young pregnant and lactating women in South Africa.

Authors:  Trisha Ramraj; Nada Abdelatif; Witness Chirinda; Fareed Abdullah; Gurpreet Kindra; Ameena Goga
Journal:  BMC Public Health       Date:  2022-06-30       Impact factor: 4.135

2.  Survival of patients with Kaposi's sarcoma in the South African antiretroviral treatment era: A retrospective cohort study.

Authors:  M M Sengayi; D Kielkowski; M Egger; L Dreosti; J Bohlius
Journal:  S Afr Med J       Date:  2017-09-22

3.  Detection and treatment of Fiebig stage I HIV-1 infection in young at-risk women in South Africa: a prospective cohort study.

Authors:  Krista L Dong; Amber Moodley; Douglas S Kwon; Musie S Ghebremichael; Mary Dong; Nasreen Ismail; Zaza M Ndhlovu; Jenniffer M Mabuka; Daniel M Muema; Karyn Pretorius; Nina Lin; Bruce D Walker; Thumbi Ndung'u
Journal:  Lancet HIV       Date:  2017-10-01       Impact factor: 16.070

4.  Age-disparate sex and HIV risk for young women from 2002 to 2012 in South Africa.

Authors:  Meredith Evan; Kathryn Risher; Nompumelelo Zungu; Olive Shisana; Sizulu Moyo; David D Celentano; Brendan Maughan-Brown; Thomas M Rehle
Journal:  J Int AIDS Soc       Date:  2016-12-26       Impact factor: 5.396

5.  Cervical cancer in women living in South Africa: a record linkage study of the National Health Laboratory Service and the National Cancer Registry.

Authors:  Tafadzwa Dhokotera; Serra Asangbeh; Julia Bohlius; Elvira Singh; Matthias Egger; Eliane Rohner; Jabulani Ncayiyana; Gary M Clifford; Victor Olago; Mazvita Sengayi-Muchengeti
Journal:  Ecancermedicalscience       Date:  2022-01-27

6.  HIV prevalence in South Africa through gender and racial lenses: results from the 2012 population-based national household survey.

Authors:  M Mabaso; L Makola; I Naidoo; L L Mlangeni; S Jooste; L Simbayi
Journal:  Int J Equity Health       Date:  2019-10-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.